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A flexible system for determining the quality of pharmaceutical products based on characteristics such as, for
example, mass, shape, hardness, size, color and surface texture is disclosed herein. The quality determination
apparatus includes a feeder assembly for sequentially dropping individual product samples upon an impact
transducer arrangement. The impact transducer generates transducer signals indicative of the physical
characteristics of each product sample. In addition, an imaging device operates to synthesize a digital image
representation of each product sample. The transducer signal and digital image representation corresponding
to each product are analyzed so as to determine the appropriate degree of quality to be associated therewith.
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ACOUSTIC AND VIDEO IIVIAGING SYSTEM FOR 
QUALITY DETERMINATION OF 
PHARMACEUTICAL PRODUCTS 
The United States government has certain rights in 
the invention pursuant to contract No. ITA 87-02 be 
tween the US. Department of Commerce and Iowa 
State University. 
This is a continuation in part of copending application 
Ser. No. 07/924,195, ?led Aug. 3, 1992, now US. Pat. 
No. 5,309,374. 
The present invention relates generally to quality 
control of pharmaceutical products, and particularly to 
quality control techniques involving acoustical and 
video signal processing. 
BACKGROUND OF THE INVENTION 
Quality control of pharmaceutical products, e. g., 
tablets and pills, has become a subject of considerable 
interest as mass production techniques have become 
increasingly prevalent within the pharmaceutical indus 
try. Methods of testing pharmaceutical products have 
involved determination of various quality parameters 
including, for example, weight, thickness and hardness. 
Conventional approaches to measuring theselparame 
ters have generally involved mechanical and electrome 
chanical testing apparatus. For example, the weight 
measurement has been accomplished by using load cell 
technology, and thickness is generally measured by 
using electromechanical sensing. In determining hard 
ness an increasing force is applied until the pill or tablet 
is ruptured. A hardness value is then calculated in ac 
cordance with an empirical relationship relating applied 
force to displacement of the product surface. Unfortu 
nately, however, this technique for hardness determina 
tion results in destruction of the product under test. 
In the agricultural industry efforts have been made to 
use computer-assisted imaging, rather than mechanical 
techniques, to facilitate recognition of defective agricul 
tural products. Computer imaging systems generally 
include a color video camera connected to a frame 
grabber. The frame grabber digitizes the image pro 
vided by the camera and relays the image information 
to a computer. Analysis of the digital image information 
may then be performed using a variety of techniques. In 
particular, the potential has been shown to discriminate 
between crop seeds and certain common contaminants 
based on image parameters such as area, perimeter, 
aspect ratio, shape factor, and the like. Other applica 
tions have involved classi?cation of diploid and tetra 
ploid ryegrass seeds, and orientation determination of 
vegetables using grey-level intensity gradients and syn 
tactic pattern recognition techniques. 
By way of example, a computer vision system for 
determining soybean quality based on size and shape 
parameters has been developed (see Misra, et al., Com 
puter Vision jbr Soybeans, presented at the 1989 Interna 
tional Summer Meeting of American Society of Agri 
cultural Engineers and Canadian Society of Agricul 
tural Engineering, Paper No. 89-3001). Images of a 
soybean are ?rst captured using a charge-coupled de 
vice (CCD) camera and digitized by a frame grabber. 
The image processing sequence is initiated by determin 
ing an outline of the soybean under analysis by search 
ing for contrasts between the portions of the image 
corresponding to the background and to the soybean 
itself. A routine is then used to ?t an ellipse to the out 
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line, since acceptably healthy soybeans were found to 
be generally elliptical in shape. While capable of suc 
cessfully discriminating between soybeans having vary 
ing degrees of quality, it is believed that the efficiency 
of the machine vision system described above could be 
improved by modi?cation of particular aspects of the 
disclosed image processing sequence. 
Concurrent with the development of the image pro 
cessing techniques described above, efforts have been 
made to develop acoustical methods of analysis based 
on the transmittance, absorption or re?ection of sound 
waves by agricultural products. These techniques are 
based on the realization that even minor changes in the 
structure or health of a product will result in variation 
of its acoustic properties. Such variations can be quanti 
tatively evaluated by analyzing the frequency compo 
nents of the sound wave. Frequency data is generally 
processed using analytic procedures such as the Fast 
Fourier Transform (FFT), which can be performed to 
identify the ways in which selected frequencies are 
absorbed, transmitted .or re?ected by the product being 
investigated. These frequency response characteristics 
can be correlated with various physical properties of 
the product related to quality. 
In the particular case of the analysis of soybeans, at 
least two types of acoustical methods have been investi 
gated (see, e.g., Misra, et al., Acoustic Properties of Soy 
beans, Transactions of the American Society of Agri 
cultural Engineers, 33(2):671—677). In a ?rst, or “acous 
tic transmission” technique, a soybean kernel is placed 
between transmitting and receiving transducers where 
the former introduces an acoustic impulse to the kernel 
and the latter records the wave transmitted through the 
kernel. Both waves, the input and the transmitted, can 
be digitally recorded and analyzed by a Fast Fourier 
Transform. The two spectra can then be compared, 
usually by dividing the transmitted wave by the input 
wave to identify frequencies that are preferentially ab 
sorbed by the kernel so as to provide an indication of 
kernel quality. Speci?cally, quality may be determined 
by analyzing the‘ differences in the absorption spectra of 
a “good” or reference soybean and the soybean under 
scrutiny. Unfortunately, the acoustic transmission spec 
tra of an ideal soybean has been found to be difficult to 
describe mathematically. Accordingly, correlation be 
tween the transmission spectra and size or mass of the 
soybean has not been possible, thus precluding effective 
quality determination. Moreover, the placement of each 
soybean between the transducers has been found to be a 
relatively slow process. 
A second, or “impact-force” method of acoustical 
characterization of soybeans involves dropping soy 
beans through a guide tube coupled to a piezoelectric 
force transducer. An impact signal generated by the 
transducer is routed to a digitizer and then to a com 
puter. A computer program then operates to derive the 
frequency spectra of the impact signal by using an FFT 
algorithm. As in the acoustic transmission technique, 
correlation of the frequency spectra of the impact signal 
with a set .of quality parameters requires the spectra to 
be mathematically described. Such a description could 
be effectuated through, for example, polynomial ap 
proximations, sine functions, or simple Bessel functions. 
Although the impact-force method has been shown to 
allow for faster determination of soybean quality, the 
frequency-domain procedure outlined above is rela 
tively computationally intensive. That is, the procedure 
requires an initial FFT conversion of the impact signal 
a 
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into the frequency domain and a subsequent parameter 
ization of the spectral characteristics so obtained. It is 
thus believed that a time-domain method for analyzing 
the transducer signal produced by an impact-force ap 
paratus would allow for a more rapid determination of 
> the quality of articles such as agricultural products, 
pharmaceutical products, and other similarly shaped 
edible material (e.g., hard candy). 
While image processing and acoustical techniques 
have each been of separate assistance in determining 
quality within the agricultural ?eld, it is believed that a 
novel system incorporating both of these methodolo 
gies would allow for increased testing ?exibility in agri 
cultural and other industrial applications. For example, 
when employed within the pharmaceutical industry 
such an integrated system would allow a user to specify 
that a set of product characteristics derived from both 
the acoustical and video realms constitute the basis for 
acceptable quality. 
OBJECTS OF THE INVENTION 
It is an object of the present invention to provide a 
system for determining the quality of pharmaceutical 
products in which is incorporated both image process 
ing and acoustical techniques. 
SUMMARY OF THE INVENTION 
The present invention addresses the need for a ?exi 
ble system for determining the quality of pharmaceuti 
cal products based on characteristics such as, for exam 
ple, mass, hardness, shape, color and surface texture. 
The inventive quality determination apparatus includes 
a feeder assembly for sequentially dropping individual 
product samples upon an impact transducer arrange 
ment. The impact transducer generates transducer sig 
nals indicative of particular physical characteristics of 
each product sample. In addition, an imaging device 
operates to synthesize a digital image representation of 
each product sample. The transducer signal and digital 
image representation corresponding to each product are 
then analyzed so as to determine the appropriate degree 
of quality to be associated therewith. 
BRIEF DESCRIPTION OF THE DRAWINGS 
Additional objects and features of the invention will 
be more readily apparent from the following detailed 
description and appended claims when taken in con 
junction with the drawings, in which; 
FIGS. 1a and 1b show a see~through side view and a 
front view, respectively, of a preferred embodiment of 
the pharmaceutical product quality determination sys 
tem of the present invention. ' 
FIG. 2 provides a detailed view of a partially disas 
sembled drop tube feeder apparatus. 
FIG. 3 shows a more detailed side view of an pharma 
ceutical product holding bin and product rejection de 
vice. 
FIG. 4 provides a block-diagrammatic overview of 
the signal.processing elements incorporated with the 
inventive pharmaceutical product quality determination 
system. I 
FIG. 5 shows a ?ow chart of a time-domain impact 
signal analysis routine. 
FIG. 6 illustratively represents the electrical output 
of the impact transducer generated in response to the 
impact of a sample pill thereupon. 
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FIG. 7 depicts a flow chart of an imaging analysis 
routine utilized by the inventive quality determination 
system. 
FIG. 8 depicts a simpli?ed illustration of a digital 
image representation of a ?eld of view encompassed by 
the imaging device included within the inventive qual 
ity determination system. 
FIG. 9 is a ?ow chart summarizing the manner in 
which the edge of an image of an pharmaceutical prod 
uct sample is distinguished from the background of a 
digital image representation thereof. 
FIG. 10 illustratively represents a set of eight direc 
tion vectors used in a boundary search operation per 
formed in connection with the digital image analysis of 
each product sample. 
FIG. 11 depicts the manner in which the shape and 
the boundary roughness of each sample pill may be 
calculated using an accumulated set of boundary pixels 
and the location center of the sample pill. 
FIG. 12 depicts the manner in which the texture, area 
and color of the surface of each sample pill may be 
calculated using a pixel-by-pixel comparison and area 
normalization. 
FIG. 13 is a flow chart depicting implementation of a 
texture analysis program. 
DESCRIPTION OF THE PREFERRED 
EMBODIMENT 
Description of Mechanical Apparatus: 
Referring to FIGS. 1a and 1b, there are shown a 
see-through side view and a front view, respectively, of 
a preferred embodiment of the pharmaceutical product 
quality determination system 10 of the present inven 
tion. The inventive system 10 is adapted to analyze 
relatively ?rm pharmaceutical products, such as pills, 
tablets and capsules. Nonetheless, it is understood that 
the speci?c mechanical implementation of the system 10 
depicted in FIG. 1 may be modi?ed to accommodate 
analysis of pharmaceutical products of varying size and 
?rmness. It is further understood that although the 
following detailed description makes speci?c reference 
to pharmaceutical pills as being the subject of analysis, 
the teachings of the present invention are equally appli 
cable to pharmaceutical tablets, capsules and the like. 
The quality determination system 10 is enclosed 
within a housing 20 and includes a drop tube feeder 
apparatus 30, a video imaging device 40, and a quality 
control rejection device 50. As is described in detail 
below, the pills or other pharmaceutical products to be 
analyzed are loaded into a roller-feed device 60 in 
cluded within the feeder apparatus 30. The device 60 
feeds one pill at a time to a drop tube 70. Each pill then 
slides down tube 70 and falls upon an impact transducer 
80. An acoustical impact signal generated by the trans 
ducer 80 is then digitized and routed to a computer (not 
shown) for analysis. Based on this analysis the quality of 
the pill may be evaluated in terms of mass and hardness. 
The pill is de?ected by the transducer 80 into a U-chan 
nel trough 90, which guides the pill to a holding bin 100. 
The video imaging subsystem 40 operates to create a 
digital image representation of the pill while it is con 
?ned in the holding bin 100. The digital image represen— 
tation of the pill is then processed so as to enable a 
determination of quality to be made on the basis of 
parameters such as lustre, color, shape and roughness. 
The inventive system 10 is designed such that a user 
may specify the extent to which each of the acoustical 
and image parameters mentioned above contributes to 
5,422,831 
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the criteria used in making an overall assessment of 
pharmaceutical product quality. As shown in FIG. 1A, 
the rejection device 50 routes pills to either accepted 
pill bin 120 or rejected pill bin 130 from the holding 
chamber 100 in accordance with such a composite qual 
ity evaluation. 
FIG. 2 depicts the drop tube feeder apparatus 30 in a 
partially disassembled con?guration. The roller-feed 
' device 60 is of a type in which a pair of rollers 190 and 
191 turn in opposite directions so as to convey each pill 
to be analyzed to the tube 70. Such a device is described 
in, for example, U.S. Pat. No. 2,661,090, entitled SORT 
ING MACHINE, issued Dec. 1, 1953, which is herein 
incorporated by reference. It is understood other appa 
ratus for providing individual pills to the tube 70 may be 
utilized without departing from the scope of the present 
invention. Referring to FIG. 2, the pills to be analyzed 
are loaded into a hopper 192. From the hopper 192 the 
pills pass through an aperture (not shown) to a rubber 
ized 3-blade star wheel 194 disposed to rotate about an 
axis A. The star wheel 194 revolves at a rate about the 
axis A selected to ensure that the delay between pills 
dropped into the tube 70 is suf?cient to allow for ade 
quate signal processing of the data accumulated for 
each pill. The spacing between the rollers 190 and 19 1 
is adjusted based on the expected size of the pills to be 
received from the star wheel 194. In the preferred em 
bodiment the rollers each rotate at a rate of approxi 
mately 3,000 rpm. 
Again referring to FIG. 2, the drop tube 70 is typi 
cally approximately 4 inches in length, is oriented at 45 
degrees relative to vertical, and extends into a rectangu 
lar coupling member 210 of the U-channel trough 90. 
The impact transducer 80 is secured by hardware 220 to 
a third bracket 230, with the third bracket 230 being 
af?xed to the coupling member 210 using hardware 240. 
The bracket 230 serves to position the impact trans 
ducer 80 such that pills falling from the drop tube 70 are 
de?ected by the transducer 80 into the 2" U-channel 
trough 90. The transducer 80 may be implemented with, 
for example, a conventional impact transducer manu 
factured by PCB Piezotronics of Depew, N.Y., part no. 
208A02. Subsequent to de?ection by the transducer 80, 
each pill slides through the U-channel trough 90 into 
the holding bin 100. 
FIG. 3 shows a more detailed side view of the hold 
ing bin 100 and rejection device 50. Also shown in FIG. 
3 is U-shaped ?uorescent lighting source 250 interposed 
between the holding bin 100 and a lens element 260 of 
the video imaging device 40. The imaging device 40 is 
designed to create a digital image representation of each 
pill entering the holding bin 100 from the trough 90. 
Such an imaging system could be conventionally real 
ized using an arrangement consisting of a camera, and a 
frame grabber. Preferably, however, the imaging de 
vice 40 will be implemented with an integrated unit 
similar to, for example, a conventional slide scanner. A 
slide scanner having suitable resolution is available from 
RasterOps Corp. of Santa Clara, Calif, as the “Ex 
presso”. The device produces either standard NTSC or 
PAL video output, and images can be captured by a 
computer using a frame grabber board. 
Referring to FIG. 3, lens element 260 is in optical 
alignment with an image axis I, while the U-shaped 
lighting source 250 partially encircles the axis I. The 
lighting source 250 provides uniform illumination over 
the surface of pills within the holding bin 100, and may 
be implemented with, for example, a 110 Volt ?uores 
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cent tube. The imaging device 40 is triggered to create 
an image of the contents of the holding bin 100 follow 
ing impact of a pill upon the transducer 80. Again, the 
impact signal generated by the transducer 80 may be 
monitored to determine the precise time at which a pill 
collides with the transducer 80. As is discussed more 
fully below, the present invention employs an object 
detection scheme to determine when a pill enters the 
?eld of view of lens element 260 upon entering holding 
bin 100 after being de?ected by the impact transducer 
80. The object detection process is repeated until the 
imaging system 40 is successful in capturing an image of 
the pill. Given that many varieties of pills are white or 
of an otherwise light color, in the presently preferred 
embodiment of the inventive system 10 the interior 
surfaces of the holding bin 100 are painted ?at black in 
order to improve the contrast of the digital image repre 
sentation. 
As is shown in FIG. 3, a photocell 270 for determin 
ing pill lustre (re?ectivity) is mounted on an interior 
surface 272 of the holding bin 100. The photocell 270 
will preferably be installed within a 2" diameter tube 
oriented downward at 45 degrees relative to the bin 
surface 272. The photocell 270 is disposed to continu 
ously provide an electrical signal indicative of the 
amount of radiant energy from the lighting source 250 
re?ected by the holding bin 100 and by any pills therein. 
Pill re?ectivity is determined by sampling the photocell 
signal, generally at a sampling rate of less than 1 MHz, 
during an interval immediately following generation of 
the impact signal. Between one and three hundred sam 
ples will typically be averaged and the result compared 
with a background photocell signal (i.e., the signal pro 
duced by photocell 270 when no pills are present within 
the holding bin 100). The results of this comparison are 
indicative of pill re?ectivity, and are stored in the mem 
ory of a host computer described below. The photocell 
270 can be conventionally realized using, for example, a 
cadmium sulphide photocell, available from Radio 
Shack, Inc., part no. 276-116. Referring to FIG. 3, the 
holding bin 100 includes a hinged ?oor 280 coupled to 
a ?rst solenoid 290. After an image of the pill within the 
holding bin 100 has been created by the imaging device 
40, solenoid 290 is actuated and operates to rotate ?oor 
280 clockwise about hinge 310. The pill resting on floor 
280 then falls through chute 320 and either is collected 
by rejected pill bin 130, or is de?ected by a hinged arm 
340 into accepted pill bin 120. If the pill has been deter 
mined to be of acceptable quality a second solenoid 360 
having a shaft 370 coupled by an “0” ring (not shown) 
to hinged arm 340 operates to rotate arm 340 clockwise 
about hinge 362. The falling pill is thereby de?ected by 
arm 340 into accepted pill bin 120. The ?rst and second 
solenoids 290 and 360 then return the ?oor 280 and arm 
340 to their respective initial positions. 
Description of Computer and Interface: 
FIG. 4 provides a block-diagrammatic overview of 
the signal processing elements incorporated within the 
inventive pharmaceutical quality determination system 
10. General computing capability is provided by a Gate 
way 386-33 microcomputer 345 operative at 33 MHz. 
The Gateway 386-33 includes an IBM PC/ AT compati 
ble microcomputer based on an Intel 80386-33 proces 
sor together with an Intel 80387-33 math co-processor, 
and also was equipped with four megabytes of random 
access memory (RAM), disk drives, and a hard drive. 
When the imaging device 40 is conventionally imple 
mented using a standard video camera, a Targa-l6 color 
5,422,831 
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image capture board (frame grabber) having 512 kilo 
bytes of static RAM enables the Gateway 386-33 to 
digitize electronic photographs from the camera. This 
enables display of the digital image representation syn 
thesized by the imaging device 40 on an analog RGB 
monitor or an NTSC color video monitor. The cap 
tured images exhibited 512 (horizontal) by 483 (verti 
cal) pixel resolution, with each pixel representing one of 
32,768 displayable colors. 
Referring to FIG. 4, a Keithly DAS-50-1M, A/D 
high speed interface card 380 for digitizing the impact 
and photocell signals is incorporated within the mi 
crocomputer. The Keithly DAS-SO provides a 1 MHz 
conversion rate, and is equipped with an on-board mem 
ory buffer for locally holding data until access is re 
quested by a transfer command from the microcom 
puter. The impact signal from transducer 80 is routed to 
channel #0 of the interface card 380, while the signal 
from the photocell 270 is received by channel #1. In 
order to access the interface card 380, a series of ASCII 
commands are sent by software resident within the 
microcomputer in accordance with the syntax for the 
card 380. Speci?cally, a procedure written in the Pascal 
computer language linked with an assembly language 
subroutine has been written to read registers of the 
interface card 380, and to control the transfer of infor 
mation from the interface card data buffer. 
Again referring to FIG. 4, the ?rst and second sole 
noids 290 and 360 are controlled by the microcomputer 
via a PIC-12 input/output 385 board in conjunction 
with an ERA-01 S-channel relay board 395. A group of 
device functions for controlling the solenoids 290 and 
360 have been written using Microsoft Macro-Assem 
bler. 
Analysis of Impact Signal: 
FIG. 5 shows a flow chart of the time-domain impact 
signal analysis routine. Again, the impact signal is gen 
erated in response to de?ection of a pill by the impact 
transducer 80. The analysis routine is commenced (step 
400) by rotating (405) a feeder within the drop tube 
apparatus 30, which results in impact of a pill upon the 
transducer 80. This impact is detected by monitoring 
(step 401 ) the electrical output of the transducer 80 in 
the manner shown in FIG. 6. As shown in FIG. 6, im 
pact is deemed to occur (410) at time t1 when the electri 
cal output of the transducer 80 rises to a value of 
(1-'|-x)V0, where V0 corresponds to the quiescent trans 
ducer output signal and the default value of x is 0.1. The 
feeder disk 160 is then stopped (step 415), and the im 
pact signal is digitized by the interface card 380 (FIG. 4) 
at a 1 MHz sampling rate (step 420). The initial 1024 
samples of the impact signal are then transferred (step 
425) from the interface card 380 to the microcomputer. 
A largest sample value (V max) is then identi?ed, and a 
group of ten sample values centered about the largest 
value (e.g., the four samples preceding Vmax and the 
?ve subsequent samples) are then avenged in order to 
determine a peak value proportional to pill mass (step 
430). The mass of each pill may be determined by insert 
ing (step 435) the peak value of the impact signal associ 
ated therewith into an empirical relationship stored 
within the microcomputer. Speci?cally, an empirical 
linear equation relating pill mass to peak impact signal 
magnitude may be formulated by dropping pills of 
known mass through the drop tube 70 and recording the 
magnitude of the impact signal corresponding to each. 
Again referring to FIG. 6, it has been found that pill 
hardness is related to the spread of the impact signal 
10 
35 
40 
45 
65 
8 
proximate the peak region. This spread corresponds to 
the time (t2—t1) separating the two points at which the 
impact signal value is equal to (l +x)V0. However, 
since the spread of the impact signal is correlated with 
mass, hardness may not be uniquely determined solely 
on the basis of the time differential t2—t1. Fortunately, 
it has also been determined that the slope of the impact 
signal proximate time t; is proportional to hardness and 
independent of pill mass. The slope at time h may be 
found (step 440) by approximating a straight line, here 
inafter referred to as the hardness line, based on a set of 
values of the impact signal between Vrnax and the im 
pact signal value of 1.1V0 at time t2. A line-?tting rou 
tine such as that described by Press, et al. in Numerical 
Recipes-The art of Scientific Computing, pp. 504-505 
may be used to ?t this set of values of the impact signal 
in a minimum sum-of-squares error sense ‘to a straight 
line corresponding to the hardness line (step 445). 
As mentioned in the Background of the Invention, 
the hardness of pharmaceutical products is generally 
measured destructively by subjecting the product to an 
increasing force until rupture occurs. Accordingly, 
product hardness (i.e., “destructive.” hardness) is often 
speci?ed in terms of the force required to cause such 
rupture. The present invention advantageously pro 
vides a non-destructive technique for determining the 
hardness associated with a given pill using the hardness 
line. The hardness line may also be used to detect flaws 
in the internal structure of the pill. Speci?cally, it has 
been found that the minimum sum-of-squares error be 
tween the set of signal values used to calculate the hard 
ness line and the hardness line itself is larger for pills 
that are broken, shrivelled, or of poor shape than for 
nondefective pills. It follows that a user-de?ned quality ‘ 
determination based on any desired combination of pill 
mass, hardness and internal structure may'be made on 
the basis of the time-domain analysis of the impact sig 
nal (step 450). For example, all pills below a certain 
mass, or those characterized by a sum-of-squares error 
larger than a prede?ned threshold, may be classi?ed as 
unacceptable. The determination of pill quality based 
on such a set of user-defined criteria concludes the 
impact signal analysis routine (step 455). 
Digital Image Analysis: 
Referring to FIG. 7, the first step (step 515) in the 
imaging analysis routine involves detecting the entrance 
of a pill into the ?eld of view of the imaging device 40. 
Since the path taken by pills falling from the trough 90 
into the holding bin 100 may be controlled by varying 
the angle of the trough 90, a search window within the 
center of the digital representation generated by the 
imaging device 40 may be monitored to detect the pres 
ence of pills. Speci?cally, FIG. 8 depicts a simpli?ed 
illustration of a digital image representation of the ?eld 
of view F of the imaging device 40, in which is included 
a pill L and upon which is superimposed a dashed line 
indicative of the location of a search window W and a 
dotted line showing the path P of pill L. A background 
reference is calculated for each search operation by 
averaging the values of ?rst and second reference pixels 
R1 and R2 located proximate the periphery of the field 
of view F. When the average value of the approxi 
mately forty pixel elements within the search window 
W differs by a predetermined threshold from the back 
ground reference, a pill is deemed to exist within the 
window W. The microcomputer then sets a flag (step 
520) to trigger the edge detection operation (FIG. 7). If 
a pill is not found within the search window W, the 
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search operation is repeated until a pill is located (steps 
525,530, 532 and 534). That is, the pill is rejected (532) 
if an edge is not detected after two or more attempts 
(530). 
FIG. 9 is a ?ow chart summarizing the manner in 
which the edge of the pill L is distinguished from the 
background of the digital image representation. In par 
ticular, the pixel elements located on a vertical line 
originating at the upper periphery of the ?eld of view F 
(FIG. 8) proximate reference pixel R1 are sequentially 
compared (steps 535 and 540) against the background 
reference. A ?rst point on the edge of the pill L is con— 
sidered to have been located (step 545) when the value 
of a pixel on this vertical line exceeds the background 
pixel value by a predetermined amount. If the lower 
boundary of the ?eld of view is reached (step 550) be 
fore ?nding a suitably bright pixel, the program pauses 
and then makes a second attempt to ?nd the pill edge. 
If the pill edge is not found after a second attempt 
(555), control is transferred to the imaging analysis 
program (592). 
Once a ?rst pixel point on the edge of the pill has been 
located, a boundary search operation is commenced 
(step 560). During the boundary search process a set of 
pixel locations located on the boundary of the pill are 
accumulated (step 565), thereby allowing the shape of 
the pill to be determined (FIG. 7, step 568). The bound 
ary search operation proceeds in a counterclockwise 
' manner around the edge of the pill, and involves ?nding 
the most likely direction of the next boundary pixel 
relative to the position of the boundary pixel last lo 
cated. Speci?cally, FIG. 10 illustratively represents a 
set of eight direction vectors used in the boundary 
search operation. Since the search proceeds counter 
clockwise, after the ?rst edge pixel has been found the 
value of a test pixel located left (i.e., in direction 2) of 
the ?rst edge pixel by a search radius is compared with 
a reference value equal to the value of the ?rst pixel less 
a prede?ned number of intensity units. If the value of 
the test pixel exceeds the background value it is deemed 
to be the second edge pixel. If the value of the test pixel 
is‘not suf?ciently large relative to the reference, a sec 
ond test pixel is identi?ed by ?nding the pixel located in 
direction 3 relative to the ?rst pixel, and separated 
therefrom by a distance approximately equivalent to the 
search radius. This process is repeated for test pixels at 
direction vectors 4, 5, 6, . . . , etc. until a suitably bright 
test pixel is found. The search process may be expedited 
by altering the direction vector initially searched after 
accumulation of each edge pixel. For example, if the 
most recent edge pixel found is located in direction 4 
relative to the previous edge pixel, direction 3 will ?rst 
be searched in attempting to locate the next 'edge pixel. 
In this way the search process “remembers” the relative 
location of the previous edge pixel and thus more effi 
ciently tracks the pill perimeter. 
The boundary search operation results in the accumu 
lation (step 570) of a set of pixels which approximate the 
pill boundary. The accuracy of the approximation may 
be increased by reducing the search radius, but such a 
reduction tends to lengthen the duration of the search 
process since more boundary points are accumulated. 
The process terminates when an edge pixel is found 
within an area of prede?ned size (e. g., a 4X4 pixel area) 
relative to the ?rst edge pixel (steps 575 and 580). Alter 
- natively, the process is aborted (steps 585, 590 and 592) 
if greater than a maximum number, typically on the 
order of one-thousand, of edge pixels are accumulated 
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without satisfying the termination criteria mentioned 
above. 
Next, the location of the center of the pill is calcu 
lated (step 595) using the accumulated set of boundary 
pixels. This calculation may be performed, for example, 
for a round pill by finding a diameter corresponding to ' 
the line between the most widely separated pixel loca 
tions. The location of the pill center may be approxi 
mated by ?nding the midpoint on this line. After the pill 
center has been determined, control is transferred back 
to the imaging analysis program (592). 
FIG. 11 depicts the manner in which the shape and 
surface texture (roughness) of each pill may be calcu- ' 
lated using the accumulated set of boundary pixels and 
the location of the center of the pill. Speci?cally, the 
boundary de?ned by the accumulated set of edge pixels 
is divided into three-hundred sixty parts (6=0 to 359 
degrees) and the distance “di”, i=0 to 359, from the 
center to each is then calculated. The distance di may 
then be plotted as a function of the angle 0 as shown by 
the edge data curve D in FIG. 11. The plot correspond 
ing to a reference ellipse R is superimposed over the 
curve D by aligning the data point corresponding to the 
major axis of the reference ellipse with the ?rst peak in 
the edge data curve D. 
The roughness of the pill may be estimated (see FIG. 
7, steps 600 and 605) by computing the variance be 
tween the edge data point di and its neighborhood di+l 
over 0:0, 1, 2, . . . , 359 degrees. Referring to FIG. 11, 
roughness may be quanti?ed as 2(di——di+ 1)2/ 360, 
where “i” ranges from 0 to 359. A user may indicate 
tolerance for roughness by specifying the maximum 
variance between the curves D and R to be exhibited by 
accepted pills. Similarly, an estimate of the extent to 
which the shape of the pill agrees with the reference 
ellipse R may be obtained by ?nding the error a be 
tween the reference ellipse R and the edge data curve 
D. Again with reference to FIG. 11, shape error may be 
quanti?ed as 2071/ 360, where “i” ranges from O to 359. 
Again, a user may specify the maximum value of shape 
. error to be associated with pills of acceptable quality. 
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Finally, an indication of pill roundness may be obtained 
by ?nding the ratio of the minor axis to the major axis. 
The program then terminates (534) after all analysis 
results have been stored (605). 
FIG. 12 depicts the manner in which the texture, area 
and color of the surface of each pill may be calculated 
using a pixel-by-pixel comparison and area normaliza 
tion. Upon completion of the edge detection routine, a 
display graphics subroutine is called which superim 
poses a solid boundary over the set of boundary points. 
In addition, a calculation box is generated so as to en 
close the solid boundary as indicated in FIG. 12. As is 
discussed below with reference to FIG. 13, a texture 
analysis program processes pixels from the upper left 
corner of the calculation box, proceeding from left to 
?ght and from top to bottom (see, e.g., steps 620, 625, 
650, 655, 660, 665 and 670). The texture analysis pro 
gram concludes (670) subsequent to processing of the 
bottom, rightmost pixel. 
FIG. 13 is a ?ow chart depicting implementation of a 
texture analysis and color determination program (610). 
Beginning in the upper left comer (steps 615 and 620) of 
the calculation box (FIG. 12), the difference in intensity 
between each pixel and its neighbor to the ?ght is accu 
mulated to produce an aggregate texture error. The 
texture error (steps 625, 630, 635, 640 and 645) is nor 
malized by dividing the aggregate texture error by the 
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surface area of the pill, wherein the surface area is deter 
mined by counting the number of pixels included within 
the pill boundary (FIG. 12). The normalized texture 
error relates to the prevalence of surface defects (e.g., 
labelling defects). 
A determination of pill color may be made when the 
imaging system 40 is implemented with a set of three 
data buffers disposed to respectively store the red, 
green and blue intensity of each pixel element. The 
aggregate intensity in each buffer may then be divided 
by the surface area of the pill in order to obtain a nor 
malized intensity. 
In the preferred embodiment acceptable pill quality is 
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includes the image analysis results associated with a 
second test batch of ?ve pills which are both broken 
and lack the identifying label imprinted on each pill 
within the reference set. 
By comparing the average parameter values in Tables 
II and III, it is seen that there exists a signi?cant devia~ 
tion between Shape_Error and Roughness. Similarly, 
there exists signi?cant deviation in the values of Sha 
pe_.Error, Roughness and Texture__Error between 
Tables II and IV. In this way the image analysis routine 
is used to provide an indication that the pills within the 
?rst and second test batches (Tables III and IV) are of 
unacceptable quality. 
TABLE II 
SHAPE MAX MIN TEXTURE COLOR 
NUMBER ERROR LENGTH LENGTH ROUGHNESS SIZE ERROR IND 
1 0.00 93.80 85.40 35.10 152.30 153.76 122.80 
2 0.00 93.80 85.30 34.50 152.10 150.36 122.13 
3 0.00 93.80 85.20 32.80 152.00 151.32 123.28 
4 0.00 93.80 85.50 35.80 151.80 157.68 122.32 
5 0.00 93.80 85.40 33.80 151.90 ’ 149.86 123.01 
Average 0.00 93.80 85.40 34.45 152.10 151.81 122.91 
Std 0.00 0.00 0.00 0.92 0.28 2.76 0.15 
TABLE III 
SHAPE MAX MIN TEXTURE COLOR 
NUMBER ERROR LENGTH LENGTH ROUGHNESS SIZE ERROR IND 
1 73.60 94.80 74.80 258.40 147.80 175.30 120.88 
2 71.00 94.70 74.80 254.40 147.90 171.40 120.13 
3 70.10 94.60 74.80 271.60 148.20 178.44 120.91 
4 75.00 94.40 74.60 256.80 148.80 173.96 120.74 
5 76.00 94.80 74.50 256.90 148.90 171.10 122.02 
Average 74.80 94.80 74.65 257.65 148.35 173.20 121.45 
Std 1.70 0.00 0.21 1.06 - 0.78 2.97 0.81 
TABLE IV ' _ 
SHAPE MAX MIN TEXTURE COLOR 
NUMBER ERROR LENGTH LENGTH ROUGHNESS SIZE ERROR IND 
1 92.70 94.20 73.60 182.20 145.50 93.68 118.16 
2 93.20 93.80 73.50 157.10 148.50 94.59 119.17 
3 85.10 94.40 74.30 156.30 146.60 94.97 118.00 
4 79.40 93.00 74.10 144.80 146.60 92.92 122.18 
5 75.40 92.40 74.70 128.30 149.50 92.78 121.70 
Average 84.05 93.30 74.15 155.25 147.50 93.23 119.93 
Std 12.23 1.27 0.78 38.11 2.83 2.50 
determined by comparing the measurements associated 
with a given pill’s shape (i.e., maximum length, mini 
mum length and shape error), roughness, size, texture 
and color with a corresponding set of reference parame 
ters. Speci?cally, the reference parameters Max 
_Length, Min_Length, Roughness, Size, Texture_Er 
ror, are determined by utilizing the image analysis pro 
gram to determine average values of the aforemen 
tioned parameters for a reference set of acceptable qual 
ity (i.e., nondefective) pills. It is anticipated that the 
reference set will be comprised of ?ve or more good 
quality pills. Deviation of the measurements associated 
with a pill under test more than a user-speci?ed amount 
from the reference parameters indicates the test pill is, 
for example, broken, missing a label, or otherwise struc 
turally defective. Table 11 below includes the image 
analysis results associated with a reference set of ?ve 
acceptable quality pills. The corresponding reference 
parameters are speci?ed in the row denoted as “Aver 
age”. In Table III there is compiled the image analysis 
results for a ?rst test batch of ?ve broken pills. Again, 
the average value of each measured parameter is set 
forth in the row labelled average. Similarly, Table IV 
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Referring to FIG. 3, pills are routed by rejection device 
50 into the accepted and rejected bins 120 and 130 on 
the basis of the quality determinations made in regard to 
the impact signal and imaging analysis routines. If either 
analysis routine indicates that a pill is of unacceptable 
quality, the pill is deposited in rejected pill bin 130. It is 
emphasized, however, that a user may specify the extent 
to which each measured physical parameter contributes 
to the overall quality assessment made by each analysis 
routine. 
While the present invention has been described with 
reference to a few speci?c embodiments, the descrip 
tion is illustrative of the invention and is not to be con 
strued as limiting the invention. Various modi?cations 
may occur to those skilled in the art without departing 
from the true spirit and scope of the invention as de?ned 
by the appended claims. For example, the teachings of 
the present invention may also be applied to various 
other edible products such as vitamin pills and tablets, 
candies and the like. 
What is claimed is: 
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1. An apparatus for determining quality of a pharma 
ceutical product of a prede?ned type, comprising: 
impact transducer means for generating a transducer 
signal indicative of a set of physical characteristics 
representative of composition of said product; 
imaging means for synthesizing a digital image repre~ 
sentation of physical appearance of said product; 
and 
signal processing means for analyzing said transducer 
signal and said digital image representation in ac 
cordance with a transducer impact signal routine 
and an image analysis routine respectively; 
whereby, based on results of said transducer impact 
signal and image analysis routines, a degree of qual 
ity is associated with said pharmaceutical product. 
2. The apparatus of claim 1 wherein said prede?ned 
type is included within the set consisting of pharmaceu 
tical pills, pharmaceutical tablets, and pharmaceutical 
capsules. 
3. The apparatus of claim 1 wherein said acoustical 
transducer means further includes a drop tube feeder 
apparatus for dropping said pharmaceutical product 
upon said transducer. 
4. The apparatus of claim 3 wherein said imaging 
means includes camera means for providing an image of 
said pharmaceutical product and for digitizing said 
image so as to create said digital image representation. 
5. The apparatus of claim 1 wherein said physical 
characteristics include mass and hardness. 
6. The apparatus of claim 5 wherein said digital image 
representation includes information pertaining to shape 
and boundary roughness of said pharmaceutical prod 
uct. _ 
7. The apparatus of claim 6 wherein said signal pro 
cessing means includes means for determining said 
shape ‘of said pharmaceutical product based on said 
digital image representation, said shape determining 
means including means for identifying a portion of said 
digital image representation as corresponding to an 
edge of said pharmaceutical product and means for 
determining a center of said product relative to said 
edge. 
8. The apparatus of claim 7 wherein said signal pro 
cessing means includes means for determining rough 
ness of said pharmaceutical product by plotting separa 
tion between prede?ned sections of said edge and said 
center and comparing said plot with a reference plot. 
9. The apparatus of claim 5 wherein said acoustical 
transducer means includes an impact transducer, said 
transducer signal being generated in response to impact 
of said pharmaceutical product upon said transducer. 
10. The apparatus of claim 9 wherein said signal pro 
cessing means includes means for performing a time 
domain analysis of said transducer signal. 
11. The apparatus of claim 10 wherein said time 
domain analysis means includes means for detecting a 
peak region of said transducer signal, wherein magni 
tude of said transducer signal at said peak region corre 
sponds to said mass of said pharmaceutical product. 
12. The apparatus of claim 11 wherein a slope of said 
peak signal at a prede?ned magnitude thereof corre 
sponds to said hardness of said pharmaceutical product. 
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13. A method for determining quality of a pharma 
ceutical product of a prede?ned type comprising the 
steps of: 
dropping said product upon an impact transducer, 
said transducer being disposed to generate a trans 
ducer signal indicative of a set of physical charac 
teristics representative of composition of said prod 
uct; 
creating an image of said product; 
digitizing said image and creating a digital image 
representation of said product; 
storing said digital image representation in computer 
memory; 
analyzing said transducer signal and digital image 
representation in accordance with a transducer 
impact signal routine and an image analysis routine 
respectively; 
whereby, based on results of said transducer impact 
signal and image analysis routines, a degree of qual 
ity is associated with said pharmaceutical product. 
14. The method of claim 13 wherein said digital 
image representation includes information pertaining to 
at least one characteristic included within the set of 
product characteristics consisting of surface texture, 
area and color. 
15. The method of claim 13 wherein said step of ana 
lyzing includes the step of determining said shape of 
said pharmaceutical product based on said digital image 
representation, said shape determining step including 
the steps of: 
identifying a portion of said digital image representa 
tion as corresponding to an edge of said pharma 
ceutical product, and 
determining a center of said product relative to said 
edge. 
16. The method of claim 15 wherein said step of ana 
lyzing includes the step of determining boundary 
roughness of said pharmaceutical product by plotting 
separation between prede?ned sections of said edge and 
said center and comparing said plot with a reference 
plot. 
17. The method of claim 16 wherein said prede?ned 
type is included within the set consisting of pharmaceu 
tical pills, pharmaceutical tablets and pharmaceutical 
capsules. 
18. The method of claim 13 wherein said physical 
characteristics include mass and hardness. 
19. The method of claim 18 wherein said digital 
image representation includes information pertaining to 
shape and boundary roughness of said pharmaceutical 
product. 
20. The method of claim 19 wherein said step of ana 
lyzing includes the step of performing a time-domain 
analysis upon said transducer signal. 
21. The method of claim 20 wherein said time-domain 
analysis step includes the step of detecting a peak region 
of said transducer signal, wherein magnitude of said 
transducer signal at said peak region corresponds to said 
mass of said pharmaceutical product. 
22. The method of claim 21 wherein said time-domain 
analysis step includes the step of determining the slope 
of said transducer signal at a predefined magnitude 
thereof wherein said slope corresponds to said hardness 
of said pharmaceutical product. 
* * * * * 
